Skip to search boxSkip to navigationSkip to main content

Natural family planning: Suitability of the CUE(TM) method for defining the time of ovulation

  • Jorge E. Moreno(corresponding author)
    ,
  • Firyal S. Khan-Dawood
    ,
  • Joseph W. Goldzieher
*Corresponding author for this work
  • Health Science Center at Houston
    ,
  • University of Texas Health Science Center at Houston
    ,
  • Univ. of Texas Medical School
    ,
  • Dept. Obstet., Gynecol. Repro. Sci.
    ,
  • Baylor College of Medicine
Research Output:
Contribution to journal
Article
Peer-review

Publication metrics

Metrics

SciVal
FWCI
0.41
SciVal
Author count
3
SciVal
Citations
12
SciVal
Paper percentile
54
Scopus
Citations

Abstract

The purpose of this study was to compare the CUE(TM) method for family planning with the Ovulation Detection Method for defining the fertile phase of the menstrual cycle. We evaluated 42 cycles from 10 women in Monterrey, Mexico, who were monitored by basal body temperatures, urinary LH, pelvic ultrasound, and the CUE monitor. The fertile phase of the cycle was adequately defined in all cycles using the CUE method, and in 35 cycles (83.3%) by the Ovulation Method. Using our protocol, the period of recommended abstinence with the CUE method is 9 days and with the Ovulation Method 11 days. The CUE method accurately defines the fertile phase of the menstrual cycle, thus improving the predictability of ovulation for women who use natural methods of birth control.

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 233-237 (5 pages)

Journal (Volume, Issue Number)

Contraception (Volume 55, Issue 4)

Publication milestones

  • Published - 01/04/1997

Publication status

Published - 01/04/1997

ISSN

0010-7824

Publication IDs

  • Scopus: 0030848462
  • PubMed: 9179455

Funding Details

Partial support for the secondary site research was provided under NIH-SBIR grant number 2 R44 HD 20222-02.
FundersFunding numbers
NIH-SBIR
2 R44 HD 20222-02
NICHD
R44HD020222